Magnesium sulfate versus phenytoin for the prevention of eclampsia

R. Sankar, E. A. Licht, M. N. Friedman, K. Duggan, G. Macdonald, M. J. Lucas, K. J. Leveno, F. G. Cunningham

Research output: Contribution to journalLetter

1 Scopus citations

Abstract

To the Editor: The study by Lucas et al. (July 27 issue)1 offered an opportunity to resolve a controversy in patient care that has divided neurologists and obstetricians for decades. However, their conclusion regarding the superiority of magnesium sulfate over phenytoin may have been influenced by several methodologic flaws. First, the loading dose of phenytoin was lower than the typical recommended dose of 18 to 20 mg per kilogram of body weight, and the reported serum levels when seizures occurred (<12.2 μg per milliliter in 8 of the 10 patients in whom eclampsia subsequently developed) are evidence of this less.

Original languageEnglish (US)
Pages (from-to)1638-1639
Number of pages2
JournalNew England Journal of Medicine
Volume333
Issue number24
DOIs
StatePublished - Dec 14 1995

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Magnesium sulfate versus phenytoin for the prevention of eclampsia'. Together they form a unique fingerprint.

  • Cite this

    Sankar, R., Licht, E. A., Friedman, M. N., Duggan, K., Macdonald, G., Lucas, M. J., Leveno, K. J., & Cunningham, F. G. (1995). Magnesium sulfate versus phenytoin for the prevention of eclampsia. New England Journal of Medicine, 333(24), 1638-1639. https://doi.org/10.1056/NEJM199512143332413